Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0G7ZT
|
|||
| Former ID |
DNCL002646
|
|||
| Drug Name |
Anti-PSCA mab
|
|||
| Drug Type |
Monoclonal antibody
|
|||
| Indication | Pancreatic cancer [ICD-11: 2C10; ICD-9: 185] | Phase 2 | [1] | |
| Company |
Agensys
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Prostate stem cell antigen (PSCA) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01608711) A Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002. U.S. National Institutes of Health. | |||
| REF 2 | Phase I rapid dose-escalation study of AGS-1C4D4, a human anti-PSCA (prostate stem cell antigen) monoclonal antibody, in patients with castration-resistant prostate cancer: a PCCTC trial. Cancer Chemother Pharmacol. 2012 Mar;69(3):763-71. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.